IOR (BSE:IORB) Beta: -0.0847 (As of Jun. 26, 2026)


BSE:IORB IOR SA BSE:IORB
22 GF Score
Price lei0.19
View Full Analysis

What is IOR Beta?

IOR BSE:IORB +5.59% 22 Beta is -0.0847 as of Jun. 26, 2026. GuruFocus rates BSE:IORB with a GF Score™ of 22/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), IOR's Beta is -0.0847.

IOR  (BSE:IORB) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

IOR Beta Related Terms

IOR Beta Historical Data

* Premium members only.

The historical data trend for IOR's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOR Beta Chart

IOR Annual Data
Trend
Beta

IOR Semi-Annual Data
Beta

BSE:IORB vs SECI, LENSF, ASNB: Beta Comparison

For the Medical Instruments & Supplies subindustry, IOR's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IOR Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IOR's Beta distribution charts can be found below:

* The bar in red indicates where IOR's Beta falls into.


BSE:IORB
22GF Score
IOR SA BSE:IORB
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOR Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.0847 mean?
IOR (BSE:IORB) has a Beta of -0.0847 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for IOR and its competitors.
Is IOR's Beta too high?
IOR's current Beta is -0.0847. Overall, IOR has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does IOR's Beta compare to SECI and LENSF?
IOR's Beta of -0.0847 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for IOR and its competitors. IOR's current Beta is -0.0847. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOR stock overvalued right now?
IOR (BSE:IORB) has a current Beta of -0.0847. The current Beta is -0.0847. IOR's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For IOR (BSE:IORB), the current Beta is -0.0847 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IOR Business Description

Address Bucovina Street No. 4, Sector 3, Bucharest, ROU, 030393
IOR SA Bucuresti operates in processing of optical glasses. It is involved in designing and performing opto-mechanical apparatus. Its products include sport optics, military optics, medical equipments, eyewear lenses and loose optics.
22GF Score

Get the complete analysis for BSE:IORB

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.19
Price